HIRONOBU HAMADA

Last Updated :2025/02/04

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Health Sciences), Professor
E-mail
hirohamadahiroshima-u.ac.jp
Self-introduction
I performed basic and clinical researches for refractory pulmonary diseases such as interstitial pneumonia and lung cancer. In addition, I performed clinical researches for pulmonary rehabilitation collaborated with several hospitals.

Basic Information

Academic Degrees

  • Doctor of Philosophy in Medical Science, Ehime University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Health Sciences : Physical Therapy
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Health Sciences
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Health Sciences

Research Fields

  • Complex systems;Biomedical engineering;Rehabilitation science / Welfare engineering

Educational Activity

Course in Charge

  1. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Development of Physical Therapy and Occupational Therapy Sciences
  2. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Development of Physical Therapy and Occupational Therapy Sciences
  3. 2024, Graduate Education (Master's Program) , First Semester, Lecture on Physical Analysis and Therapeutic Sciences
  4. 2024, Graduate Education (Master's Program) , First Semester, Seminar on Physical Analysis and Therapeutic Sciences
  5. 2024, Graduate Education (Master's Program) , Second Semester, Seminar on Physical Analysis and Therapeutic Sciences
  6. 2024, Graduate Education (Master's Program) , Year, Research on Physical Analysis and Therapeutic Sciences
  7. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Lecture on Physical Analysis and Therapeutic Sciences
  8. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Physical Analysis and Therapeutic Sciences
  9. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Physical Analysis and Therapeutic Sciences
  10. 2024, Liberal Arts Education Program1, 4Term, Human health and the society
  11. 2024, Undergraduate Education, Intensive, Practice of Medicine I
  12. 2024, Undergraduate Education, Intensive, Practice of Medicine II
  13. 2024, Undergraduate Education, Second Semester, Graduation Theses
  14. 2024, Undergraduate Education, First Semester, Internal medicine Ⅰ
  15. 2024, Undergraduate Education, Second Semester, Internal medicine II
  16. 2024, Undergraduate Education, First Semester, Rehabilitation for internal disorders
  17. 2024, Undergraduate Education, Second Semester, Practice in rehabilitation for internal disorders
  18. 2024, Undergraduate Education, 2Term, Introduction to Rehabilitation Science
  19. 2024, Undergraduate Education, 2Term, Introduction to Rehabilitation Science
  20. 2024, Undergraduate Education, 1Term, Sports Medicine
  21. 2024, Undergraduate Education, First Semester, Internal medicine Ⅰ
  22. 2024, Undergraduate Education, Second Semester, Internal medicine II
  23. 2024, Undergraduate Education, First Semester, Rehabilitation for internal disorders
  24. 2024, Graduate Education (Doctoral Program) , Year, Advanced Research on Development of Physical Therapy and Occupational Therapy Sciences
  25. 2024, Graduate Education (Master's Program) , 1Term, Advanced Lecture on Preventive Medicine for Evidence-based Health Guidance A
  26. 2024, Graduate Education (Master's Program) , First Semester, Advanced Lecture on Health Science 3(Experiment Research)

Research Activities

Academic Papers

  1. Intestinal overgrowth of Candida albicans exacerbates bleomycin-induced pulmonary fibrosis in mice with dysbiosis, JOURNAL OF PATHOLOGY, 261(2), 227-237, 202310
  2. Hypoxia-inducible factor 1ホア modulates interstitial pneumonia-mediated lung cancer progression, JOURNAL OF TRANSLATIONAL MEDICINE, 21(1), 20231127
  3. Nestin and Notch3 collaboratively regulate angiogenesis, collagen production, and endothelial-mesenchymal transition in lung endothelial cells, CELL COMMUNICATION AND SIGNALING, 21(1), 20230921
  4. Exhaled Nitric Oxide and Olfactory Dysfunction in Patients with Asthma: Association with Chronic Rhinosinusitis, MEDICINA-LITHUANIA, 59(10), 202310
  5. Effect of Dupilumab in a Patient With Severe Asthma Complicated With Recurrent Anaphylaxis: A Case Report, JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 33(3), 230-232, 2023
  6. Clinical characteristics of extrapulmonary nontuberculous mycobacteria infections in comparison with pulmonary infections: A single-center, retrospective study in Japan, JOURNAL OF INFECTION AND CHEMOTHERAPY, 29(9), 875-881, 202309
  7. Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases, RESPIRATORY MEDICINE, 212, 202306
  8. Predictive value of serum high-mobility group box 1 levels for checkpoint inhibitor pneumonitis, RESPIROLOGY, 28(4), 380-388, 202304
  9. Preserved ratio impaired spirometry with or without restrictive spirometric abnormality, SCIENTIFIC REPORTS, 13(1), 20230220
  10. Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal Transition, CANCERS, 15(4), 202302
  11. Association of the RAGE/RAGE-ligand axis with interstitial lung disease and its acute exacerbation, RESPIRATORY INVESTIGATION, 60(4), 531-542, 202207
  12. Effects of L-Arginine on impaired blood fluidity after high-intensity exercise: An in vitro evaluation, Clinical Hemorheology and Microcirculation, 82(1), 1-12, 2022
  13. Association Between Patient Preference for Inhaler Medications and Asthma Outcomes, JOURNAL OF ASTHMA AND ALLERGY, 15, 1539-1547, 2022
  14. Predictive role of circulatory levels of high-mobility group box 1 for radiation pneumonitis in patients with non-small cell lung cancer treated with definitive thoracic radiotherapy, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 27(11), 1698-1705, 202211
  15. Hochuekkito Combined with Pulmonary Rehabilitation in Apathetic Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Pilot Trial, JOURNAL OF CLINICAL MEDICINE, 11(19), 202210
  16. Possible Therapeutic Utility of anti-Cell Adhesion Molecule 1 Antibodies for Malignant Pleural Mesothelioma, FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 10, 20220712
  17. Effects of soy protein isolate and soy peptide preload on gastric emptying rate and postprandial glycemic control in healthy humans, JOURNAL OF PHYSIOLOGICAL ANTHROPOLOGY, 41(1), 20220627
  18. Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer, BMC PULMONARY MEDICINE, 22(1), 20220630
  19. Role of Soluble Receptor for Advanced Glycation End Products in Postoperative Fibrotic Lung Injury, ANNALS OF THORACIC SURGERY, 113(5), 1617-1623, 202205
  20. Accelerated decline in lung function in adults with a history of remitted childhood asthma, EUROPEAN RESPIRATORY JOURNAL, 59(1), 20220101
  21. Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non-small cell lung cancer, CANCER SCIENCE, 112(1), 369-379, 202101
  22. Correlations of forced oscillometric bronchodilator response with airway inflammation and disease duration in asthma, CLINICAL RESPIRATORY JOURNAL, 15(1), 48-55, 202101
  23. Concomitant emphysema might increase the false-negative rate of urinary antigen tests in patients with pneumococcal pneumonia: results from a retrospective study, EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 40(4), 871-877, 202104
  24. Autoantibody Positivity Is a Risk Factor for Chemotherapy-induced Exacerbation of Interstitial Pneumonia in Lung Cancer, ANTICANCER RESEARCH, 41(3), 1497-1506, 202103
  25. Prognostic Significance of EGFR Gene Mutation in Patients With EGFR Mutated Non-small Cell Lung Cancer Who Received Best Supportive Care Alone, ANTICANCER RESEARCH, 41(5), 2661-2667, 202105
  26. Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients, SCIENTIFIC REPORTS, 11(1), 20210512
  27. Risk factors associated with increased discontinuation rate of trimethoprim-sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort study, PULMONARY PHARMACOLOGY & THERAPEUTICS, 67, 202104
  28. A machine-learning based approach to quantify fine crackles in the diagnosis of interstitial pneumonia A proof-of-concept study, MEDICINE, 100(7), 20210219
  29. IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis, PLOS ONE, 16(6), 20210604
  30. Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis, ORPHANET JOURNAL OF RARE DISEASES, 16(1), 20210703
  31. Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity, STEM CELL RESEARCH & THERAPY, 12(1), 20210823
  32. Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis, STEM CELL RESEARCH & THERAPY, 12(1), 20210916
  33. Analysis of microRNA Expression in Liquid-Based Cytology Samples May Be Useful for Primary Lung Cancer Diagnosis, AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 156(4), 644-652, 202110
  34. Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 88(5), 857-865, 202111
  35. Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 25(1), 74-81, 202001
  36. Treatment rationale and design of the PROLONG study: safety and efficacy of pembrolizumab as first-line therapy for elderly patients with non-small cell lung cancer, JOURNAL OF THORACIC DISEASE, 12(3), 1079-1084, 202003
  37. Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis, RESPIROLOGY, 25(3), 275-280, 202003
  38. Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis, RESPIRATORY RESEARCH, 21(1), 20200611
  39. Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease, RESPIRATORY MEDICINE, 172, 202010
  40. Extent of pulmonary fibrosis on high-resolution computed tomography is a prognostic factor in patients with pleuroparenchymal fibroelastosis, RESPIRATORY INVESTIGATION, 58(6), 465-472, 202011
  41. Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor-Induced Interstitial Lung Disease Among Patients With Nonlung Cancers, JAMA NETWORK OPEN, 3(11), 20201112
  42. Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1, CANCER LETTERS, 442, 31-39, 2019
  43. High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery, MEDICINE, 98(5), 201902
  44. Cerebral embolism during edoxaban administration for venous thromboembolism in a patient with lung adenocarcinoma A case report, MEDICINE, 98(12), 201903
  45. L-cysteine improves blood fluidity impaired by acetaldehyde: In vitro evaluation, PLOS ONE, 14(3), 20190329
  46. Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts, JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 23(4), 2984-2994, 201904
  47. Performance Status Is a Risk Factor for Depression before the Diagnosis of Lung Cancer Patients, INTERNAL MEDICINE, 58(7), 915-920, 2019
  48. Suplatast tosilate reduces radiation-induced lung injury in mice through suppression of oxidative stress, FREE RADICAL BIOLOGY AND MEDICINE, 136, 52-59, 20190520
  49. Comparison of anti-aminoacyl-tRNA synthetase antibody-related and idiopathic non-specific interstitial pneumonia, RESPIRATORY MEDICINE, 152, 44-50, 201906
  50. Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer, RESPIRATORY INVESTIGATION, 57(5), 451-459, 201909
  51. C-C Motif Chemokine Ligand 15 May Be a Useful Biomarker for Predicting the Prognosis of Patients with Chronic Hypersensitivity Pneumonitis, RESPIRATION, 98(3), 212-220, 201909
  52. Chemotherapy-associated Acute Exacerbation of Interstitial Lung Disease Shortens Survival Especially in Small Cell Lung Cancer, ANTICANCER RESEARCH, 39(10), 5725-5731, 201910
  53. Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with Polyangiitis, INTERNAL MEDICINE, 58(21), 3129-3132, 2019
  54. Baseline High-Resolution CT Findings Predict Acute Exacerbation of Idiopathic Pulmonary Fibrosis: German and Japanese Cohort Study, JOURNAL OF CLINICAL MEDICINE, 8(12), 201912
  55. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 81(1), 131-139, 201801
  56. Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinoma, LUNG CANCER, 119, 21-24, 201805
  57. Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma, EUROPEAN RESPIRATORY JOURNAL, 51(5), 20180501
  58. Bevacizumab with Single-agent Chemotherapy in Previously Treated Non-squamous Non-small-cell Lung Cancer: Phase II Study, IN VIVO, 32(5), 1155-1160, 2018
  59. Use of proton pump inhibitors is associated with increased mortality due to nosocomial pneumonia in bedridden patients receiving tube feeding, GERIATRICS & GERONTOLOGY INTERNATIONAL, 18(8), 1215-1218, 201808
  60. Intratracheal Administration of siRNA Dry Powder Targeting Vascular Endothelial Growth Factor Inhibits Lung Tumor Growth in Mice, MOLECULAR THERAPY-NUCLEIC ACIDS, 12, 698-706, 20180907
  61. Plasminogen activator inhibitor-1 serves an important role in radiation-induced pulmonary fibrosis, EXPERIMENTAL AND THERAPEUTIC MEDICINE, 16(4), 3070-3076, 201810
  62. Alternate-day administration of S-1 for elderly patients with advanced non-small-cell lung carcinoma: A prospective feasibility study, MOLECULAR AND CLINICAL ONCOLOGY, 9(5), 539-544, 201811
  63. Effects of Hochuekkito combined with pulmonary rehabilitation in patients with chronic obstructive pulmonary disease, EXPERIMENTAL AND THERAPEUTIC MEDICINE, 16(6), 5236-5242, 201812
  64. Posture and firmness changes in a pressure-relieving air mattress affect cough strength in elderly people with dysphagia, PLOS ONE, 13(12), 20181211
  65. Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody A retrospective cohort study, MEDICINE, 97(49), 201812
  66. The effect of body weight support on predicted locomotive physical activity, The Journal of Physical Therapy Science, 30, 759-763, 2018
  67. FAM13A polymorphism as a prognostic factor in patients with idiopathic pulmonary fibrosis, RESPIRATORY MEDICINE, 123, 105-109, 201702
  68. MUC1 in lung adenocarcinoma: cross-sectional genetic and serological study, BMC CANCER, 17, 20170412
  69. Central command increases muscular oxygenation of the non-exercising arm at the early period of voluntary one-armed cranking, PHYSIOLOGICAL REPORTS, 5(7), 201704
  70. Suplatast tosilate protects the lung against hyperoxic lung injury by scavenging hydroxyl radicals, FREE RADICAL BIOLOGY AND MEDICINE, 106, 1-9, 201705
  71. AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis, RESPIROLOGY, 22(5), 965-971, 201707
  72. Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets, BMC MEDICAL GENETICS, 18, 20170818
  73. CLINICAL AND MOLECULAR FEATURES OF RAPIDLY PROGRESSIVE CHRONIC HYPERSENSITIVITY PNEUMONITIS, SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 34(1), 48-57, 2017
  74. Oxidative stress in cigarette smokers and patients with chronic obstructive pulmonary disease, Oxidants and Antioxidants in Medical Science, 6, 19-24, 2017
  75. Chronic Intestinal Pseudo-obstruction and Orthostatic Hypotension Associated with Small Cell Lung Cancer that Improved with Tumor Reduction after Chemoradiotherapy, INTERNAL MEDICINE, 56(19), 2627-2631, 2017
  76. AGER rs2070600 polymorphism elevates neutrophil-lymphocyte ratio and mortality in metastatic lung adenocarcinoma, ONCOTARGET, 8(55), 94382-94392, 20171107
  77. Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis, INTERNAL MEDICINE, 56(24), 3327-3331, 2017
  78. Effect of Different Levels of Pressure Relieving Air-Mattress Firmness on Cough Strength, PLOS ONE, 11(1), 20160107
  79. Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-beta-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts, PLOS ONE, 11(2), 20160209
  80. Cardiac parasympathetic outflow during dynamic exercise in humans estimated from power spectral analysis of P-P interval variability, EXPERIMENTAL PHYSIOLOGY, 101(3), 397-409, 20160301
  81. The effect of exercise on blood fluidity: Use of the capillary model to assess the clogginess of blood, CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 61(4), 559-569, 2016
  82. Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis, DISEASE MARKERS, 2016
  83. Long-term pulmonary complications of chemical weapons exposure in former poison gas factory workers, INHALATION TOXICOLOGY, 28(8), 343-348, 201607
  84. Inhibition of PAI-1 Limits Tumor Angiogenesis Regardless of Angiogenic Stimuli in Malignant Pleural Mesothelioma, CANCER RESEARCH, 76(11), 3285-3294, 20160601
  85. Oxidative stress induced by smoking and exercise., International Journal of Medical and Biological Frontiers, 22, 203-213, 2016
  86. Combination therapy with sivelestat and recombinant human soluble thrombomodulin for ARDS and DIC patients, DRUG DESIGN DEVELOPMENT AND THERAPY, 8, 1211-1219, 2014
  87. Phase II trial of S-1 as third-line or further chemotherapy in patients with advanced non-small-cell lung cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19(6), 1005-1010, 201412
  88. Phase-dependent modulation of corticospinal excitability during the observation of the initial phase of gait, SOMATOSENSORY AND MOTOR RESEARCH, 31(4), 209-213, 201412
  89. Cigarette smoking does not induce plasma or pulmonary oxidative stress after moderate-intensity exercise., JOURNAL OF PHYSICAL THERAPY SCIENCE, 26, 413-415, 2014
  90. Differential contribution of ACh-muscarinic and b-adrenergic receptors to vasodilatation in noncontracting muscle during voluntary one-legged excercise., PHYSIOLOGICAL REPORTS, 2, e12202, 2014
  91. Characteristics of Patients with Severe Heart Failure Exhibiting Exercise Oscillatory Ventilation, CLINICAL AND EXPERIMENTAL HYPERTENSION, 35(4), 267-272, 2013
  92. Evidence for centrally-induced cholinergic vasodilatation in skeletal muscle during voluntary one-legged cycling and motor imagery in humans, PHYSIOLOGICAL REPORTS, 1(4), 20130901
  93. EGCG induces human mesothelioma cell death by inducing reactive oxygen species and autophagy, CANCER CELL INTERNATIONAL, 13, 20130223
  94. Plasma oxidative stress is induced by single-sprint anaerobic exercise in young cigarette smokers, CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 33(3), 241-244, 201305
  95. Usefulness of a selective neutrophil elastase inhibitor, sivelestat, in acute lung injury patients with sepsis, DRUG DESIGN DEVELOPMENT AND THERAPY, 7, 305-316, 2013
  96. Pulmonary Oxidative Stress Is Induced by Maximal Exercise in Young Cigarette Smokers, NICOTINE & TOBACCO RESEARCH, 14(2), 243-247, 201202
  97. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer, INTERNATIONAL JOURNAL OF CANCER, 130(2), 377-387, 20120115
  98. The evaluation of the internal quality control of respiratory function tests, 37(3), 287-292, 20120601
  99. Antitumor activity of MEK and PI3K inhibitors against malignant pleural mesothelioma cells in vitro and in vivo, INTERNATIONAL JOURNAL OF ONCOLOGY, 41(2), 449-456, 201208
  100. Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma, INTERNATIONAL JOURNAL OF ONCOLOGY, 41(5), 1610-1618, 201211
  101. Attenuation of the Muscle Metaboreflex in Patients with Type 2 Diabetes, JOURNAL OF PHYSICAL THERAPY SCIENCE, 24(8), 721-724, 201209
  102. Antitussive effect of bakumondoto a fixed kampo medicine (six herbal components) for treatment of post-infectious prolonged cough: Controlled clinical pilot study with 19 patients, PHYTOMEDICINE, 18(8-9), 630-633, 20110615
  103. Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease, RESPIRATORY RESEARCH, 12, 20110726

Publications such as books

  1. 2014, Acute Lung Injury: Epidemiology, Health Effects and Therapeutic Treatment Strategies., Pharmacological therapies for acute respiratory distress syndrome., Nova Science Publishers, 2014, Scholarly Book, Single work, Hironobu Hamada
  2. 2013, Handbook on Reactive oxygen species (ROS): formation mechanisms, physiological roles and common harmful effects, Oxidative stress in lungs and blood induced by smoking and exercise, Nova Science Publishers, 2013, Scholarly Book, Joint work, Taito S, Hamada H